194 related articles for article (PubMed ID: 2432090)
1. Acute myeloblastic leukemia in paroxysmal nocturnal hemoglobinuria. Evidence of evolution from the abnormal paroxysmal nocturnal hemoglobinuria clone.
Devine DV; Gluck WL; Rosse WF; Weinberg JB
J Clin Invest; 1987 Jan; 79(1):314-7. PubMed ID: 2432090
[TBL] [Abstract][Full Text] [Related]
2. Paroxysmal nocturnal hemoglobinuria with myelofibrosis: progression to acute myeloblastic leukemia.
Nakahata J; Takahashi M; Fuse I; Nakamori Y; Nomoto N; Saitoh H; Tatewaki W; Imanari A; Takeshige T; Koike T
Leuk Lymphoma; 1993 Dec; 12(1-2):137-42. PubMed ID: 7512853
[TBL] [Abstract][Full Text] [Related]
3. [Immunocytochemical staining of decay-accelerating factor (DAF) on erythrocytes: paroxysmal nocturnal hemoglobinuria (PNH)].
Kobayashi T; Nakazawa M; Sato Y; Tomiyama J; Ninomiya H; Abe T; Terasawa T; Shichishima T; Fujita T
Rinsho Ketsueki; 1992 Feb; 33(2):162-6. PubMed ID: 1378912
[TBL] [Abstract][Full Text] [Related]
4. Expression of decay-accelerating factor on hematopoietic progenitors and their progeny cells grown in cultures with fractionated bone marrow cells from normal individuals and patients with paroxysmal nocturnal hemoglobinuria.
Okuda K; Kanamaru A; Ueda E; Kitani T; Okada N; Okada H; Kakishita E; Nagai K
Exp Hematol; 1990 Nov; 18(10):1132-6. PubMed ID: 1698649
[TBL] [Abstract][Full Text] [Related]
5. PIG-A, DAF and proto-oncogene expression in paroxysmal nocturnal haemoglobinuria-associated acute myelogenous leukaemia blasts.
Stafford HA; Nagarajan S; Weinberg JB; Medof ME
Br J Haematol; 1995 Jan; 89(1):72-8. PubMed ID: 7530480
[TBL] [Abstract][Full Text] [Related]
6. [Paroxysmal nocturnal hemoglobinuria (PNH) deficiency of major complement-regulatory membrane proteins on erythrocytes].
Ninomiya H; Kobayashi T; Abe T
Rinsho Ketsueki; 1991 Jun; 32(6):612-7. PubMed ID: 1716325
[TBL] [Abstract][Full Text] [Related]
7. Relationship between decay accelerating factor deficiency, diminished acetylcholinesterase activity, and defective terminal complement pathway restriction in paroxysmal nocturnal hemoglobinuria erythrocytes.
Medof ME; Gottlieb A; Kinoshita T; Hall S; Silber R; Nussenzweig V; Rosse WF
J Clin Invest; 1987 Jul; 80(1):165-74. PubMed ID: 2439544
[TBL] [Abstract][Full Text] [Related]
8. Discordant and heterogeneous expression of GPI-anchored membrane proteins on leukemic cells in a patient with paroxysmal nocturnal hemoglobinuria.
Shichishima T; Terasawa T; Hashimoto C; Ohto H; Takahashi M; Shibata A; Maruyama Y
Blood; 1993 Apr; 81(7):1855-62. PubMed ID: 7681703
[TBL] [Abstract][Full Text] [Related]
9. Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria.
Kinoshita T; Medof ME; Silber R; Nussenzweig V
J Exp Med; 1985 Jul; 162(1):75-92. PubMed ID: 2409211
[TBL] [Abstract][Full Text] [Related]
10. Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor.
Nicholson-Weller A; March JP; Rosenfeld SI; Austen KF
Proc Natl Acad Sci U S A; 1983 Aug; 80(16):5066-70. PubMed ID: 6576376
[TBL] [Abstract][Full Text] [Related]
11. Increased plasma decay-accelerating factor levels in paroxysmal nocturnal hemoglobinuria.
Nakakuma H; Nagakura S; Kawaguchi T; Horikawa K; Kagimoto T; Kawakita M; Tomita M; Takatsuki K
Int J Hematol; 1992 Apr; 55(2):121-5. PubMed ID: 1380843
[TBL] [Abstract][Full Text] [Related]
12. Molecular Pathogenesis of Paroxysmal Nocturnal Hemoglobinuria.
Lin LI; Chen YC; Lin JK
Hematology; 1997; 2(5):399-406. PubMed ID: 27405407
[TBL] [Abstract][Full Text] [Related]
13. Decay-accelerating factor is present on paroxysmal nocturnal hemoglobinuria erythroid progenitors and lost during erythropoiesis in vitro.
Moore JG; Frank MM; Müller-Eberhard HJ; Young NS
J Exp Med; 1985 Oct; 162(4):1182-92. PubMed ID: 2413153
[TBL] [Abstract][Full Text] [Related]
14. Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria.
Pangburn MK; Schreiber RD; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5430-4. PubMed ID: 6225118
[TBL] [Abstract][Full Text] [Related]
15. [Dysfunction and deficiency of decay-accelerating factor (DAF) demonstrated in the lymphocytes from a patient with paroxysmal nocturnal hemoglobinuria (PNH)].
Tomiyama J; Ninomiya H; Nakazawa M; Nagasawa T; Yoda Y; Abe T
Rinsho Ketsueki; 1989 Jun; 30(6):845-9. PubMed ID: 2477566
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of aberrant decay-accelerating factor proteins by affected paroxysmal nocturnal hemoglobinuria leukocytes.
Carothers DJ; Hazra SV; Andreson SW; Medof ME
J Clin Invest; 1990 Jan; 85(1):47-54. PubMed ID: 1688570
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of glycosyl-phosphatidylinositol anchored proteins on paroxysmal nocturnal haemoglobinuria (PNH) neutrophils and monocytes: heterogeneous deficiency of decay-accelerating factor (DAF) and CD16 on PNH neutrophils.
Kawakami Z; Ninomiya H; Tomiyama J; Abe T
Br J Haematol; 1990 Apr; 74(4):508-13. PubMed ID: 1693286
[TBL] [Abstract][Full Text] [Related]
18. Enhanced complement-susceptibility and dysfunction of lymphocytes in paroxysmal nocturnal haemoglobinuria (PNH).
Tomiyama J; Ninomiya H; Abe T
Br J Haematol; 1990 Dec; 76(4):540-4. PubMed ID: 1702310
[TBL] [Abstract][Full Text] [Related]
19. Interactions of the platelets in paroxysmal nocturnal hemoglobinuria with complement. Relationship to defects in the regulation of complement and to platelet survival in vivo.
Devine DV; Siegel RS; Rosse WF
J Clin Invest; 1987 Jan; 79(1):131-7. PubMed ID: 2432087
[TBL] [Abstract][Full Text] [Related]
20. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
Rosenfeld SI; Jenkins DE; Leddy JP
J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
